Literature DB >> 22727780

Thiorhodamines containing amide and thioamide functionality as inhibitors of the ATP-binding cassette drug transporter P-glycoprotein (ABCB1).

Alexandra Orchard1, Gregory A Schamerhorn, Brandon D Calitree, Geri A Sawada, Tip W Loo, M Claire Bartlett, David M Clarke, Michael R Detty.   

Abstract

Twelve thiorhodamine derivatives have been examined for their ability to stimulate the ATPase activity of purified human P-glycoprotein (P-gp)-His(10), to promote uptake of calcein AM and vinblastine into multidrug-resistant, P-gp-overexpressing MDCKII-MDR1 cells, and for their rates of transport in monolayers of multidrug-resistant, P-gp-overexpressing MDCKII-MDR1 cells. The thiorhodamine derivatives have structural diversity from amide and thioamide functionality (N,N-diethyl and N-piperidyl) at the 5-position of a 2-thienyl substituent on the thiorhodamine core and from diversity at the 3-amino substituent with N,N-dimethylamino, fused azadecalin (julolidyl), and fused N-methylcyclohexylamine (half-julolidyl) substituents. The julolidyl and half-julolidyl derivatives were more effective inhibitors of P-gp than the dimethylamino analogues. Amide-containing derivatives were transported much more rapidly than thioamide-containing derivatives.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22727780      PMCID: PMC3400123          DOI: 10.1016/j.bmc.2012.05.075

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  38 in total

1.  Structure-function relationships of multidrug resistance P-glycoprotein.

Authors:  Ilza K Pajeva; Christoph Globisch; Michael Wiese
Journal:  J Med Chem       Date:  2004-05-06       Impact factor: 7.446

2.  Benzotriazole-assisted thioacylation.

Authors:  Alan R Katritzky; Rachel M Witek; Valerie Rodriguez-Garcia; Prabhu P Mohapatra; James W Rogers; Janet Cusido; Ashraf A A Abdel-Fattah; Peter J Steel
Journal:  J Org Chem       Date:  2005-09-30       Impact factor: 4.354

3.  P-glycoprotein. Associations between domains and between domains and molecular chaperones.

Authors:  T W Loo; D M Clarke
Journal:  J Biol Chem       Date:  1995-09-15       Impact factor: 5.157

4.  Drug transport by reconstituted P-glycoprotein in proteoliposomes. Effect of substrates and modulators, and dependence on bilayer phase state.

Authors:  P Lu; R Liu; F J Sharom
Journal:  Eur J Biochem       Date:  2001-03

Review 5.  Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells.

Authors:  Ying Huang; Wolfgang Sadée
Journal:  Cancer Lett       Date:  2005-10-05       Impact factor: 8.679

6.  Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities.

Authors:  A H Dantzig; R L Shepard; K L Law; L Tabas; S Pratt; J S Gillespie; S N Binkley; M T Kuhfeld; J J Starling; S A Wrighton
Journal:  J Pharmacol Exp Ther       Date:  1999-08       Impact factor: 4.030

7.  Substrate-induced conformational changes in the transmembrane segments of human P-glycoprotein. Direct evidence for the substrate-induced fit mechanism for drug binding.

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  J Biol Chem       Date:  2003-02-27       Impact factor: 5.157

Review 8.  ABC multidrug transporters: structure, function and role in chemoresistance.

Authors:  Frances J Sharom
Journal:  Pharmacogenomics       Date:  2008-01       Impact factor: 2.533

Review 9.  Targeting multidrug resistance in cancer.

Authors:  Gergely Szakács; Jill K Paterson; Joseph A Ludwig; Catherine Booth-Genthe; Michael M Gottesman
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

10.  A method for the determination of inorganic phosphate in the presence of labile organic phosphate and high concentrations of protein: application to lens ATPases.

Authors:  S Chifflet; A Torriglia; R Chiesa; S Tolosa
Journal:  Anal Biochem       Date:  1988-01       Impact factor: 3.365

View more
  4 in total

1.  Selective photodepletion of malignant T cells in extracorporeal photopheresis with selenorhodamine photosensitizers.

Authors:  Zachariah A McIver; Mark W Kryman; Young Choi; Benjamin N Coe; Gregory A Schamerhorn; Michelle K Linder; Kellie S Davies; Jacqueline E Hill; Geri A Sawada; Jason M Grayson; Michael R Detty
Journal:  Bioorg Med Chem       Date:  2016-06-02       Impact factor: 3.641

2.  Targeting T Cell Bioenergetics by Modulating P-Glycoprotein Selectively Depletes Alloreactive T Cells To Prevent Graft-versus-Host Disease.

Authors:  Zachariah A McIver; Jason M Grayson; Benjamin N Coe; Jacqueline E Hill; Gregory A Schamerhorn; Tymish Y Ohulchanskyy; Michelle K Linder; Kellie S Davies; Roy S Weiner; Michael R Detty
Journal:  J Immunol       Date:  2016-07-25       Impact factor: 5.422

3.  Synthesis and Properties of Heavy Chalcogen Analogues of the Texas Reds and Related Rhodamines.

Authors:  Mark W Kryman; Gregory A Schamerhorn; Jacqueline E Hill; Brandon D Calitree; Kellie S Davies; Michelle K Linder; Tymish Y Ohulchanskyy; Michael R Detty
Journal:  Organometallics       Date:  2014-05-02       Impact factor: 3.876

4.  Selenorhodamine photosensitizers for photodynamic therapy of P-glycoprotein-expressing cancer cells.

Authors:  Jacqueline E Hill; Michelle K Linder; Kellie S Davies; Geri A Sawada; Janet Morgan; Tymish Y Ohulchanskyy; Michael R Detty
Journal:  J Med Chem       Date:  2014-10-01       Impact factor: 7.446

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.